Travere Therapeutics Inc (TVTX) stock news · rev $490.7M
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
This TVTX news page leads with what Travere Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for TVTX yet. We will not pad this page with generic market recap.
Latest reported TVTX revenue for 2025-12-31 was $490.7M. Net income was -$25.5M. Revenue was up 110.5% from 2024-12-31 to 2025-12-31. TVTX currently screens at market cap $1.33B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the TVTX stock page; for the tape open the quote page.
TVTX stock news FAQ
What are TVTX's latest revenue and net income?
Latest cached Travere Therapeutics Inc (TVTX) revenue for Dec 31, 2025 was $490.7M. Net income was -$25.5M. Statements: https://lician.com/financials/tvtx
How did TVTX revenue change from the prior cached period?
Cached Travere Therapeutics Inc (TVTX) revenue was up 110.5% from $233.2M (Dec 31, 2024) to $490.7M (Dec 31, 2025). Statements: https://lician.com/financials/tvtx
What is TVTX's market cap?
Travere Therapeutics Inc (TVTX) market cap is $1.33B on the latest cached fundamentals snapshot.
What kind of company is TVTX?
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Where is TVTX stock news listed?
Cached stock news for Travere Therapeutics Inc (TVTX) is listed at https://lician.com/news/tvtx. Filings: https://lician.com/sec/tvtx
Not investment advice.